U
Uniskin
Advocates rational skin care methods, allowing users to understand the inherent characteristics of their skin and body, and choose a skin care method that suits them
About Uniskin
Uniskin, operated by Yinai (Shanghai) Biotechnology Co., Ltd., is a science-based skincare company established in 2018 with a specific focus on the anti-aging market for Chinese consumers. The company was founded by Dr. Le Du, whose background uniquely positions the firm. Dr. Du graduated from UCLA with a degree in molecular and cell biology, earned a medical doctorate from Albany Medical College, and practiced as a resident physician at a UCLA-affiliated hospital. This clinical experience, where he observed skin as an indicator of internal health, spurred him to return to China in 2016 to research the specificities of Chinese skin and subsequently launch the Uniskin brand.
The firm's business model is centered on direct-to-consumer sales of cosmetic products through online channels like Tmall and offline placements in high-end retailers. Uniskin targets consumers, particularly new white-collar workers and mothers around the age of 25, who are beginning to focus on preventative anti-aging routines. The company's strategy initially involved a highly personalized "quantitative skincare" approach using skin testing, but it later pivoted to developing broadly applicable products based on its accumulated data. A key milestone was the 2019 launch of its "Smiling Eye Cream," which became a bestseller and established the brand's presence in the competitive eye cream segment. The company has secured significant funding, including an Angel round from Sequoia Capital, a Series A round led by Hony Capital, and a Series B round of over 100 million RMB led by MSA Capital.
Uniskin's core offering is a range of skincare products formulated specifically for the characteristics of Chinese skin, which research suggests is more prone to sensitivity. The product lines include the eye care series, the "Black Gravity" anti-aging series, and the soothing series. A foundational element of Uniskin's R&D is its proprietary UNI-HUB, a database containing multi-omic skin data from nearly 30,000 Chinese individuals, which informs its product development. This data-driven approach, combining genomics with environmental and lifestyle factors, allows the company to create targeted formulations. The company collaborates with global chemical companies like Lubrizol to develop advanced ingredients, differentiating its products in a crowded market. This scientific foundation is complemented by a distinct brand aesthetic, recognized with a Red Dot Design Award, which helps it appeal to a younger demographic seeking both efficacy and sophisticated design.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Dec 2021 | $14M | $55M | MSA Capital · VMS Group | — |
Growth signals
Latest recorded traffic for Uniskin is 2.1K monthly website visits, up 624.1% over the last three months. Uniskin's team declined 12.5% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
MSA Capital
VMS Group
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Uniskin on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Uniskin’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







